{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0000","upperLimit":"0.6204","value":"0.2857"},{"groupId":"OG001","lowerLimit":"0.4354","upperLimit":"0.8374","value":"0.6364"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"22"}],"units":"Participants"}],"description":"4-year EFS (probability of no relapse, secondary malignancy, or death after 4 years in the study).","dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"% Change in SUVmax From Baseline to Week 4 < 40%"},{"id":"OG001","title":"% Change in SUVmax From Baseline to Week 4 >= 40%"}],"paramType":"NUMBER","populationDescription":"452 participants were excluded due to ineligibility or absence of SUVmax evaluation at baseline and week 4.","reportingStatus":"POSTED","timeFrame":"4 years","title":"Compare Event Free Survival (EFS) With Respect to the Level of % Change in FDG PET Maximum Standard Uptake Value (SUVmax) at Week 4","type":"SECONDARY","unitOfMeasure":"Probability"}